Integrum AB (publ) (STO:INTEG.B)

Revenue by Segment

Financials in millions SEK. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017
Medical Products	96.14M	97.52M	110.46M	77.55M	60.82M
Medical Products Growth	-1.42%	-11.71%	42.44%	27.50%	38.87%
Total	96.14M	97.52M	110.46M	77.55M	60.82M
Total Growth	-1.42%	-11.71%	42.44%	27.50%	38.87%

Revenue by Geography

Financials in millions SEK. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017
USA	72.47M	72.06M	73.30M	58.44M	43.09M
USA Growth	0.56%	-1.68%	25.43%	35.63%	25.71%
Rest of The World	18.92M	15.40M	26.81M	11.97M	8.20M
Rest of The World Growth	22.85%	-42.56%	124.00%	45.94%	49.97%
Sweden	-	3.64M	4.01M	3.87M	4.44M
Sweden Growth	-	-9.33%	3.71%	-12.82%	32.37%
Total	91.39M	91.10M	104.12M	74.27M	55.72M
Total Growth	0.31%	-12.50%	40.19%	33.29%	29.31%

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 6, 2026

Data Sources Report a data error